Health care regulation agency Frier Levitt has analyzed FDA enforcement steps from “analysis only” peptide distributors. Their summary: the FDA considers a product’s classification dependant on its meant use, not its disclaimers. When Sites incorporate dosage guides, reconstitution Guidance, or back